Scientific Program

  • Thursday, September 30
  • Friday, October 1
  • Saturday, October 2

Friday, October 1

[SY06]
AACC-KSLM Session
Data aggregation and integration in laboratory medicine: How to build prediction models and learn from multi-institutional data

Date & Time Oct. 1 (Fri), 08:00-09:30 Channel CHANNEL1 Language Eng
Chair(s)
  1. Eun Hee Lee, Green Cross Laboratories, Korea
    Junghan Song, Seoul National University College of Medicine, Korea
Speaker(s)
  1. A path to sharing and integrating traceable, clinical laboratory data
    Thomas Durant, Yale University School of Medicine, USA
  2. How to harmonize multi-site clinical laboratory data: Lessons from the national COVID cohort collaborative (N3C)
    Patrick Mathias, University of Washington, USA
  3. Building prediction models that that can be transferred across clinical practices
    Daniel Herman, University of Pennsylvania, USA

[SY07]
CLSI-KSLM Session
Essential CLSI guidelines for good laboratory practice

In this session, we will review the essential CLSI guidelines for good laboratory practice and discuss how to apply them to actual laboratory work.

Date & Time Oct. 1 (Fri), 08:00-09:30 Channel CHANNEL2 Language Eng
Chair(s)
  1. Sang Hoon Song, Seoul National University College of Medicine, Korea
    Sung-Eun Cho, Green Cross Laboratories, Korea
Speaker(s)
  1. POCT 15: Point of care testing for infectious diseases; Relevant in 2021?
    Sheldon Campbell, Yale School of Medicine, USA
  2. Assessment of equivalence or suitability of specimen types for medical laboratory measurement procedures (CLSI EP35)
    Victoria Petrides, Abbott Laboratories, USA
  3. CLSI updates in MM13: Collection, transport, preparation, and storage of specimens for molecular methods
    Jieun Kim, Soonchunhyang University College of Medicine, Korea

[SY08]
Education workshop for residents and new specialists in laboratory medicine

This session is intended for residents in training, new starters, or laboratory medicine specialists with interests of basic knowledge. We will be covering the very basics and practical aspects of laboratory medicine in the fields of laboratory management, diagnostic hematology, clinical microbiology, and diagnostic immunology.

Date & Time Oct. 1 (Fri), 08:00-09:30 Channel CHANNEL3 Language Kor
Chair(s)
  1. Woo In Lee, College of Medicine, Kyung Hee University, Korea
    Jung-Sook Ha, Keimyung University School of Medicine, Korea
Speaker(s)
  1. Various certifications of laboratory medicine
    You La Jeon, Green Cross Laboratories, Korea
  2. Flow cytometric analysis of hematologic neoplasms
    Sang Mee Hwang, Seoul National University Bundang Hospital, Korea
  3. Interpretating antimicrobial susceptibility results
    Jeong Su Park, Seoul National University College of Medicine, Korea
  4. Laboratory tests for organ transplantation
    Yongjung Park, Yonsei University College of Medicine, Korea

[OP01]
Oral Presentation 01: Clinical Chemistry, Diagnostic Immunology

Date & Time Oct. 1 (Fri), 09:40-10:40 Channel CHANNEL1 Language Eng
Chair(s)
  1. Hyung-Doo Park, Sungkyunkwan University School of Medicine, Korea
    So Young Kang, Kyung Hee University School of Medicine, Korea
Speaker(s)
    PT code Presentation title/Speaker
    OC-01 Biomarker rule-in or rule-out in patients with acute diseases for validation of acute kidney injury in the emergency department (BRAVA): A multicenter study evaluating urinary TIMP-2/IGFBP7
    Hanah Kim, Konkuk University School of Medicine, Korea
    OC-03 Evaluation of free light chain analysis method using Siemens Atellica CH 930 instrument and N Latex FLC Reagent
    Shin Young Yun, Yonsei University College of Medicine, Korea
    OC-12 Assessment of Martin's formula for the estimation of low-density lipoprotein cholesterol levels in Indian patients with type 2 diabetes mellitus
    Shrimanjunath Sankanagoudar, All India Institute of Medical Sciences, India
    OI-01 Association of pre-operative non-HLA antibodies with kidney allograft rejection
    Inseong Oh, Seoul National University Hospital, Korea
    OI-04 Prognostic utility of Procalcitonin, Presepsin and VACO index for predicting 30-day mortality in COVID-19
    Mikyoung Park, Yeungnam University College of Medicine, Korea
    OI-05 The relationship of regulatory T cells and lymphocyte subpopulation with treatment response and survival in gastric cancer.
    Hyunjung Kim, The Catholic University College of Medicine, Korea

[OP02]
Oral Presentation 02: Diagnostic Genetics, Diagnostic Hematology

Date & Time Oct. 1 (Fri), 09:40-10:40 Channel CHANNEL2 Language Eng
Chair(s)
  1. Myungshin Kim, College of Medicine, The Catholic University of Korea, Korea
    Mina Hur, Konkuk University School of Medicine, Korea
Speaker(s)
    PT code Presentation title/Speaker
    OG-07 Incidence and risk factor analysis in BRCA1/2 pathogenic variants according to medical reimbursement criteria: 3-year single-center study
    Jee Ah Kim, Sungkyunkwan University School of Medicine, Korea
    OG-11 Aberrant transcript usage induces homologous recombination deficiency and predicts therapeutic responses
    Eunhae Cho, GC Genome, Korea
    OG-12 Intronic LINE-1 insertion in SLCO1B3 causing rotor syndrome is highly prevalent in East Asian populations but rare in other populations
    Young-gon Kim, GC Genome, Korea
    OH-01 Germline predisposition and somatic mutation profiles of therapy-related myeloid neoplasms and multiple primary tumors
    Jiwon Yun, Seoul National University College of Medicine, Korea
    OH-02 Characteristics of RAS pathway mutations in juvenile myelomonocytic leukemia: A single-institute study from Korea
    Hoon Seok Kim, Seoul St. Mary's Hospital, Korea
    OH-08 A prospective multicentric study on the role of blood coagulation and fibrinolysis in the emergence of ARDS in patients with new coronavirus pneumonia (COVID-19)
    Tushar Sehgal, All India Institute of Medical Sciences, India

[OP03]
Oral Presentation 03: Clinical Microbiology, General Laboratory Medicine, Transfusion Medicine

Date & Time Oct. 1 (Fri), 09:40-10:40 Channel CHANNEL3 Language Eng
Chair(s)
  1. Sue Shin, Seoul National University College of Medicine, Korea
    Young Ae Lim, Ajou University School of Medicine, Korea
Speaker(s)
    PT code Presentation title/Speaker
    OM-02 Mutation analysis in bedaquiline and delamanid high MIC mycobacterium tuberculosis
    Hee Joo Lee, The Korean Institute of Tuberculosis, Korea
    OM-03 Development of a judgment algorithm for image-based rapid fluconazole susceptibility testing of candida species
    Seung Yeob Lee, Jeonbuk National University Medical School and Hospital, Korea
    OGL-01 Reagent lot-to-lot change should be considered when top-down measurement uncertainty estimation using internal quality control data is performed
    Hyunjung Gu, University of Ulsan College of Medicine, Korea
    OGL-03 Implementation of alert system for early diagnosis of acute kidney injury: Indian perspective
    Barnali Das, Kokilaben Hospital, India
    OT-01 A novel 18.9 kb deletion extending beyond the 5′ end of RHD is associated with del phenotype
    Tae Yeul Kim, Sungkyunkwan University School of Medicine, Korea
    OT-02 ABO antibody measurement using complement-dependent cytotoxicity
    Hee-Jeong Youk, University of Ulsan College of Medicine, Korea

[PL02]
AACC-KSLM Session
Big data and AI in laboratory medicine: Progress and challenges

Date & Time Oct. 1 (Fri), 11:00-12:00 Channel CHANNEL1 Language Eng
Chair(s)
  1. Gye Cheol Kwon, Chungnam National University College of Medicine, Korea
Speaker(s)
  1. Big data and AI in laboratory medicine: Progress and challenges
    Stephen Master, American Association for Clinical Chemistry, USA

[EW07]
Siemens Healthineers

Especially in the early days of the COVID-19 pandemic, the proliferation of low-quality assays and many clinical unknowns have led to controversies about the utility of SARS-CoV-2 serology assays. This workshop aims to present current guidelines and best practices around the use of these tests:
- In clinical practice as an aid in diagnosis/ staging of COVID-19 or post-acute COVID-19 syndromes
- For public health surveillance of the pandemic and effectiveness of control measures
- For research studies investigating the magnitude and durability of immune responses to natural infection and vaccination

Date & Time Oct. 1 (Fri), 12:00-12:30 Channel CHANNEL1 Language Eng
Chair(s)
  1. Dong Hee Whang, Inje University College of Medicine, Korea
Speaker(s)
  1. Clinical utility of anti-SARS-CoV-2 serology assays
    Pearline Teo, Siemens Healthineers, Asia Pacific, Singapore

[EW08]
JW Bio Science

All large-scale clinical laboratories are expected to achieve quality results while improving laboratory performance. This workshop shares experience of two major hospital laboratories improved by JEOL clinical chemical analyzer. (1) improved TAT (2) cost reduction (3) higher patient satisfaction

Date & Time Oct. 1 (Fri), 12:00-12:30 Channel CHANNEL2 Language Eng
Chair(s)
  1. Dal Sik Kim, Chonbuk National University Medical School, Korea
Speaker(s)
  1. Laboratory efficiency: Driving faster TAT for clinical chemistry and gaining effective use of resources
    Tetsuro Sugiura, Kansai Medical University Medical Center, Japan

[EW09]
QIAGEN Korea

The present review is discussing the role of PIK3CA mutations in various types of solid malignancies in terms of prevalence, potential correlation with clinicopathological parameters correlated with PIK3CA mutations detection in plasma DNA.

Date & Time Oct. 1 (Fri), 12:00-12:30 Channel CHANNEL3 Language Eng
Chair(s)
  1. Woochang Lee, University of Ulsan College of Medicine, Korea
Speaker(s)
  1. Introduction of PIK3CA mutation testing in plasma in cancer patients. Molecular target or prognostic factor?
    Andrzej Urban, Medical Affairs Manager, Qiagen, UK

[KS02]
Scientific uncertainties during the COVID-19 pandemic and challenges for the future

Date & Time Oct. 1 (Fri), 12:40-13:20 Channel CHANNEL1 Language Eng
Chair(s)
  1. Mi-Na Kim, University of Ulsan College of Medicine, Korea
Speaker(s)
  1. Scientific uncertainties during the COVID-19 pandemic and challenges for the future
    Sotirios Tsiodras, University of Athens Medical School, Greece

[EW10]
Roche Diagnostics Korea

Analytical performance evaluation and workflow analysis of coagulation analyzer Roche cobas t-511 was studied. Performance evaluation with ACL TOP 750 coagulation system was done and workflow of cobas t-511 coagulation system was evaluated to be considered in performing routine coagulation tests in clinical laboratory.

Date & Time Oct. 1 (Fri), 13:30-14:00 Channel CHANNEL1 Language Eng
Chair(s)
  1. Hyun Kyung Kim, Seoul National University College of Medicine, Korea
Speaker(s)
  1. Analytical performance evaluation and workflow analysis of coagulation analyzer Roche Cobas t-511
    Rojin Park, Soonchunhyang University College of Medicine, Korea

[EW11]
Beckman Coulter Korea

Discuss the data and clinical protocols supporting the key roles that IL-6, procalcitonin (PCT) and high sensitivity troponin can play in the management of these diverse diseases in the critical care setting.

Date & Time Oct. 1 (Fri), 13:30-14:00 Channel CHANNEL2 Language Eng
Chair(s)
  1. Kyung Eun Song, Kyungpook National University School of Medicine, Korea
Speaker(s)
  1. IL-6, PCT and high sensitivity troponin in critical care disease management
    Poh Tze Wei, Beckman Coulter Diagnostics, Singapore

[EW12]
bioMérieux KOREA

Sepsis is a condition in which the whole body is infected with microorganisms and has a serious inflammatory reaction. The failure to perform proper treatment can result in disability, shock, or death. We will share the result of clinical trials conducted for sepsis diagnosis, and we will share how this study has been applied to sepsis management in our hospitals. We also explore how 24/7 laboratory operations have a positive impact on patient care.

Date & Time Oct. 1 (Fri), 13:30-14:00 Channel CHANNEL3 Language Eng
Chair(s)
  1. Yeon Joon Park, The Catholic University of Korea, Seoul St. Mary's Hospital, Korea
Speaker(s)
  1. Improving the management of patients with sepsis: Experience with a blood culture diagnostic clinical trial
    Ana Verónica Halperin, Clinical microbiologist Ramon y Cajal Hospital Madrid, Spain

[SY09]
Challenges in the coagulation laboratory

The inherent challenge of the coagulation test is that the coagulation events in vivo and in vitro are not identical. Despite the elaborate guidelines and technological advances to overcome this limitation, the diagnosis of coagulation disease remains a challenge. In this session, we will first discuss ways to guarantee relevance of the coagulation test by enhancing the understanding of the preanalytical variable of coagulation testing. Next, we would like to review the updated findings on Von Willebrand disease, which is known as the most common bleeding disorder but difficult to diagnose. Lastly, we would like to discuss the difficulties in the establishment of therapeutic range of heparin, an everlasting major component of the initial treatment of thrombotic diseases.

Date & Time Oct. 1 (Fri), 14:00-15:30 Channel CHANNEL1 Language Eng
Chair(s)
  1. Jin-Yeong Han, Dong-A University College of Medicine, Korea
    Seongsoo Jang, University of Ulsan College of Medicine, Korea
Speaker(s)
  1. Preanalytical variables in coagulation testing
    Robert Gosselin, University of California Davis CA, USA
  2. Advances in laboratory diagnosis and understanding of von Willebrand disease
    Jaewoo Song, Yonsei University College of Medicine, Korea
  3. Practical difficulty in the establishment of heparin therapeutic range
    Seongsoo Jang, University of Ulsan College of Medicine, Korea

[SY10A]
Asia Session
COVID-19 laboratory diagnosis in Asian countries

Date & Time Oct. 1 (Fri), 14:00-15:40 Channel CHANNEL2 Language Eng
Chair(s)
  1. Hwan Sub Lim, Seoul Clinical Laboratories, Korea
    Namhee Ryoo, Keimyung University School of Medicine, Korea
Speaker(s)
  1. COVID-19 laboratory diagnosis in Asian countries: Myanmar’s live experience
    Yi Yi Kyaw, Advanced Molecular Research Centre, Myanmar
  2. COVID-19 laboratory diagnosis in Mongolia
    Ertsuud Munkhtuvshin Oyundelger, Mongolian Association of Laboratory Medicine, Mongolia
  3. COVID-19 laboratory diagnosis in India
    Praveen Sharma, All India Institute of Medical Sciences (AIIMS), India
  4. COVID-19 laboratory diagnosis in Thailand: Role of department of medical sciences
    Archawin Rojanawiwat, National Institute of Health of Thailand, Thailand
  5. COVID-19 laboratory diagnosis in Taiwan
    Po-Ren Hsueh, National Taiwan University College of Medicine, Taiwan

[SY11]
COVID-19 and infection control

Date & Time Oct. 1 (Fri), 14:00-16:00 Channel CHANNEL3 Language Kor
Chair(s)
  1. Wonkeun Song, Hallym University College of Medicine, Korea
    Hee-Won Moon, Konkuk University School of Medicine, Korea
Speaker(s)
  1. 감염병 예방을 위한 역학교육
    Seung-sik Hwang, Department of Public Health Sciences, Seoul National University Graduate School of Public Health, Korea
  2. Strategies of social distancing and laboratory diagnosis after COVID-19 vaccination in Korea
    Jae-Seok Kim, Hallym University College of Medicine, Korea
  3. 코로나19 판데믹과 항생제 내성
    Hyukmin Lee, Yonsei University College of Medicine, Korea

[SY12]
Current management of chronic hepatitis B infection and future aspects of immunologic diagnostic approach

This session will introduce current management of chronic hepatitis B (CHB) infection and brand new immunologic diagnostic approach of CHB infection. This will cover updated interesting issues to expect future application of CHB diagnosis.

Date & Time Oct. 1 (Fri), 15:40-17:10 Channel CHANNEL1 Language Eng
Chair(s)
  1. Kyeong-Hee Kim, Dong-A University College of Medicine, Korea
    Eun Young Song, Seoul National University College of Medicine, Korea
Speaker(s)
  1. Challenges in HBV diagnosis and the new role of HBsAg in HBV management
    Ed Gane, Department of Medicine, the University of Auckland, New Zealand
  2. Hepatitis B virus: Up-to-date overview of management
    Jeong-Hoon Lee, Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Korea
  3. Brand new immunologic approaches to diagnose chronic hepatitis B virus infection
    Jong-Han Lee, Yonsei University Wonju College of Medicine, Korea

[SY10B]
Asia Session
COVID-19 laboratory diagnosis in Asian countries

Date & Time Oct. 1 (Fri), 15:50-17:10 Channel CHANNEL2 Language Eng
Chair(s)
  1. Mi-Kyung Lee, Chung-Ang University College of Medicine, Korea
    Jeong Hwan Shin, Inje University College of Medicine, Korea
Speaker(s)
  1. COVID-19 laboratory diagnosis in Japan
    Jun Saegusa, Kobe University Hospital, Japan
  2. COVID-19 laboratory diagnosis in Indonesia
    Aryati Aryati, Indonesian Society of Clinical Pathology, Indonesia
  3. COVID-19 laboratory diagnosis in Korea: Our experiences and future
    Ki Ho Hong, Yonsei University College of Medicine, Korea
  4. COVID-19 testing process: Experiences from Vietnam
    Huy Huu Nguyen, University Medical Center HCMC, Vietnam

[KS03]
Neutralizing antibodies and COVID-19: vaccine, VOCs and immune longevity

Date & Time Oct. 1 (Fri), 17:20-18:00 Channel CHANNEL1 Language Eng
Chair(s)
  1. Yunjung Cho, Korea University College of Medicine, Korea
Speaker(s)
  1. Neutralizing antibodies and COVID-19: Vaccine, VOCs and immune longevity
    Linfa Wang, Duke-NUS Medical School, Singapore